SB 840: Cancer Clinical Trials
GENERAL BILL by Simmons
Cancer Clinical Trials; Requiring cancer clinical trial programs to inform prospective patient subjects of specified reimbursements for ancillary and travel expenses which may be available to them and their caregivers if they participate in a cancer clinical trial; authorizing corporations, individuals, public and private foundations, health care providers, and other stakeholders to offer financial assistance to support approved reimbursements of ancillary and travel expenses for patient subjects in a cancer clinical trial and their caregivers, etc.
Effective Date: 7/1/2020
Last Action: 3/14/2020 Senate - Died in Health Policy
Bill Text: Web Page | PDF
Last Action: 3/14/2020 Senate - Died in Health Policy
Bill Text: Web Page | PDF
Senate Committee References:
- Health Policy (HP)
- Appropriations Subcommittee on Health and Human Services (AHS)
- Appropriations (AP)
-
Bill History
Date Chamber Action 11/8/2019 Senate • Filed
11/21/2019 Senate • Referred to Health Policy; Appropriations Subcommittee on Health and Human Services; Appropriations -SJ 64
1/14/2020 Senate • Introduced -SJ 64
3/14/2020 Senate • Indefinitely postponed and withdrawn from consideration
• Died in Health Policy
-
SB 840, Original Filed Version (Current Bill Version) Posted 11/8/2019 at 8:35 AM
Bill Text: Web Page | PDF Analyses: None Citations - Statutes (1)
Citation Catchline Location in Bill Location In Bill Help 385.2021 Page 2 (pdf)